Related Experiment Video
Updated: Jul 17, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Iron-overload-induced ferroptosis in mouse cerebral toxoplasmosis promotes brain injury and could be inhibited by
Chong Wang1,2, Linding Xie1,2, Yien Xing1,2
1Department of Health Inspection and Quarantine, School of Public Health, Anhui Medical University, Hefei, China.
Abstract:
Iron is a trace metal element that is essential for the survival of cells and parasites. The role of iron in cerebral toxoplasmosis (CT) is still unclear. Deferiprone (DFP) is the orally active iron chelator that binds iron in a molar ratio of 3:1 (ligand:iron) and promotes urinary iron excretion to remove excess iron from the body. The aims of this experiment were to observe the alterations in iron in brains with Toxoplasma gondii (T. gondii) acute infections and to investigate the mechanism of ferroptosis in CT using DFP. We established a cerebral toxoplasmosis model in vivo using TgCtwh3, the dominant strains of which are prevalent in China, and treated the mice with DFP at a dose of 75 mg/kg/d. Meanwhile, we treated the HT-22 cells with 100 μM DFP for half an hour and then infected cells with TgCtwh3 in vitro. A qRT-PCR assay of TgSAG1 levels showed a response to the T. gondii burden. We used inductively coupled plasma mass spectrometry, an iron ion assay kit, Western blot analysis, glutathione and glutathione disulfide assay kits, a malonaldehyde assay kit, and immunofluorescence to detect the ferroptosis-related indexes in the mouse hippocampus and HT-22 cells. The inflammatory factors interferon-γ, tumor necrosis factor-α, transforming growth factor-β, and arginase 1 in the hippocampus and cells were detected using the Western blot assay. Hematoxylin and eosin staining, electron microscopy, and the Morris water maze experiment were used to evaluate the brain injuries of the mice. The results showed that TgCtwh3 infection is followed by the activation of ferroptosis-related signaling pathways and hippocampal pathological damage in mice. The use of DFP led to ferroptosis resistance and attenuated pathological changes, inflammatory reactions and T. gondii burden of the mice, prolonging their survival time. The HT-22 cells with TgCtwh3 activated the ferroptosis pathway and was inhibit by DFP in vitro. In TgCtwh3-infected cells, inflammatory response and mitochondrial damage were severe, but these effects could be reduced by DFP. Our study elucidates the mechanism by which T. gondii interferes with the host's iron metabolism and activates ferroptosis, complementing the pathogenic mechanism of CT and further demonstrating the potential value of DFP for the treatment of CT.
Insights
Iron dysregulation in cerebral toxoplasmosis (CT) activates ferroptosis. The iron chelator Deferiprone (DFP) reversed this, reducing parasite burden and brain damage in mice.
Area of Science:
- Neuroparasitology
- Iron Metabolism
- Cellular Death Pathways
Background:
- Cerebral toxoplasmosis (CT) pathogenesis involving iron is poorly understood.
- Iron is essential for parasite survival and host cell function.
- Deferiprone (DFP) is an iron chelator that promotes iron excretion.
Purpose of the Study:
- To investigate iron alterations in the brain during acute Toxoplasma gondii (T. gondii) infection.
- To explore the role of ferroptosis in CT.
- To evaluate DFP's therapeutic potential for CT.
Main Methods:
- Established a mouse model of cerebral toxoplasmosis using TgCtwh3 strain.
- Treated mice and HT-22 cells with DFP.
- Assessed T. gondii burden, ferroptosis markers, inflammatory factors, and brain pathology.
- Utilized qRT-PCR, ICP-MS, Western blot, and microscopy.
Main Results:
- T. gondii infection activated ferroptosis pathways and caused hippocampal damage.
- DFP treatment conferred ferroptosis resistance, reduced inflammation and parasite load, and improved survival.
- DFP inhibited the ferroptosis pathway in infected HT-22 cells in vitro.
- DFP mitigated mitochondrial damage and inflammation in infected cells.
Conclusions:
- T. gondii manipulates host iron metabolism, inducing ferroptosis in CT.
- DFP demonstrates therapeutic potential by counteracting ferroptosis and reducing pathology.
- This study elucidates CT mechanisms and supports DFP as a treatment option.

